Literature DB >> 213422

Binding sites for angiotensin II in human mononuclear leucocytes.

K Shimada, Y Yazaki.   

Abstract

Angiotensin II binding sites were demonstrated in human mononuclear leucocytes by use of [125I]angiotensin II. The binding of [125I]angiotensin II to mononuclear leucocytes was rapid and reversible. The abilities of unlabeled compounds to displace [125I]angiotensin II were proportional to their abilities to displace labeled hormone in adrenal and smooth muscle membrane preparations. The Scatchard plot revealed two apparent orders of binding sites. The affinity constants were comparable with those for binding sites in other main target tissues of angiotensin II.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 213422     DOI: 10.1093/oxfordjournals.jbchem.a132183

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

1.  Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway.

Authors:  C Nataraj; M I Oliverio; R B Mannon; P J Mannon; L P Audoly; C S Amuchastegui; P Ruiz; O Smithies; T M Coffman
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 2.  Immune and inflammatory role in renal disease.

Authors:  John D Imig; Michael J Ryan
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

Review 3.  Immunomodulating peptides.

Authors:  G H Werner; F Floc'h; D Migliore-Samour; P Jollès
Journal:  Experientia       Date:  1986-05-15

4.  A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation.

Authors:  Giulia Fornasa; Marc Clement; Emilie Groyer; Anh-Thu Gaston; Jamila Khallou-Laschet; Marion Morvan; Kevin Guedj; Srini V Kaveri; Alain Tedgui; Jean-Baptiste Michel; Antonino Nicoletti; Giuseppina Caligiuri
Journal:  Cardiovasc Res       Date:  2012-01-31       Impact factor: 10.787

Review 5.  Is hypertension an immunologic disease?

Authors:  David G Harrison; Tomasz J Guzik; Jorg Goronzy; Cornelia Weyand
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

6.  Effect of two phenanthrene alkaloids on angiotensin II-induced leukocyte-endothelial cell interactions in vivo.

Authors:  Rossana Estellés; Javier López-Martín; Lara Milian; José-Enrique O'Connor; Magdalena Martínez-Losa; Miguel Cerdá-Nicolás; Edet M Anam; María Dolores Ivorra; Andrew C Issekutz; Julio Cortijo; Esteban J Morcillo; Maria Amparo Blázquez; Maria-Jesús Sanz
Journal:  Br J Pharmacol       Date:  2003-10-14       Impact factor: 8.739

7.  Effect of angiotensin II on macrophage functions.

Authors:  G Fóris; B Dezsö; G A Medgyesi; G Füst
Journal:  Immunology       Date:  1983-03       Impact factor: 7.397

Review 8.  Cardiovascular effects of losartan and its relevant clinical application.

Authors:  Feichao Xu; Caiping Mao; Yali Hu; Can Rui; Zhice Xu; Lubo Zhang
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 9.  Inflammation in Renal Diseases: New and Old Players.

Authors:  Vinicius Andrade-Oliveira; Orestes Foresto-Neto; Ingrid Kazue Mizuno Watanabe; Roberto Zatz; Niels Olsen Saraiva Câmara
Journal:  Front Pharmacol       Date:  2019-10-08       Impact factor: 5.810

10.  Distribution of a novel binding site for angiotensins II and III in mouse tissues.

Authors:  Felicia M Rabey; Vardan T Karamyan; Robert C Speth
Journal:  Regul Pept       Date:  2010-02-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.